3/22/2017

Headline March 23, 2017/ ''' EASTERN *PROMISE* EASTERN '''


''' EASTERN *PROMISE* EASTERN '''




*SINGAPOREAN  MARKETING GENIUS  DAVID GOH* : -Rich, Handsome-and scrupulously ethical;    -fit as a fiddle,  is one great personal friend of many-tier merit

When David, whom I lovingly call, Dave now,    - when he speaks on Marketing, and Security, and High Speed cameras, and Philosophy, I just shut-up and listen, to this very wise and  great man.

With gentle breeze blowing, and Islamabad in Proud Pakistan, yawning and awning the arrival of Spring,    -Pakistan.  the first conceptual fleeting host of !WOW!  -the World Students Society: Dave decided to delight and amaze me, on an intense tutorial in * Alternative Medicine*  from China.

''Hey, A'', he tells me, 'puffing away at his nth cigarette in the last one hour, Chinese medicine is miracle bound. I straighten up and focus, as he narrates one personal story after another.

All of these unique happenings and even miracles, I will cover in the very days ahead.

God bless. Ya Dave! All points taken, as I get the heavens bound research to the very Base Line for the future. 
.     
THE TRADE IN MEDICINES between the West and China is not all one way, for very, very sure.

Traditional Chinese medicine   -acupuncture, herbal mixtures and other remedies   -is gaining in popularity. According to Kalorama Information, a market-research firm based in New York-

American sales of herbal remedies, vitamins and minerals, including traditional medicines, in 1998, did reach $12.3 billion in 2011, almost double the level in 1996 .

Although western patients might shy away from bear paw or tiger parts, they are lapping up ephedra for colds and ginseng for enervation. 

Such medicines have gained from patients' switch from conventional, prescribed therapies to alternative, over-the-counter remedies, sold as nutritional supplements to prevent the real illness.

In China, traditional remedies are still going strong, having survived both 50 years of communism and competition from western pharmaceuticals. 

Traditional Chinese medical practitioners and hospitals exist alongside those dispensing new-fangled western medicine.

According to Joanne McManus, author of a report on the future of the Asian Drugs industry, China has  1,000  traditional manufacturers turning out 4,000 different products -about half the drugs China consumes.

But firms making traditional remedies are, like their pharmaceutical counterparts, feeling the pinch of government reforms and cuts in the national drug budget: as many as a third of traditional producers are in the red.

One solution may be to boost China's exports; at the moment, only 4% of the world's $15 billion market in herbal products comes from China. The government wants to increase reports to $2 billion by 2008.

Foreigners are interested in traditional medicine. Some drug firms, such as Pfizer, are collaborating with the Chinese government to find out how traditional therapies act. 

Smaller companies, among them Pharmakon, based in Hong Kong and Marco Polo Technologies, based in Bethesda, Maryland, are also applying modern technologies to standardised traditional remedies, before launching them in America. 

Putting traditional medicine on a  scientific footing is vital to its continued success in the West.

In America herbal supplements now escape the requirements of safety and efficacy imposed by the drug regulators because they state that they are ''not intended to treat, cure or prevent any disease'' a hollow claim.

However, the authorities went uneasy. 
Somewhat recent study by the  California's Department of Health Services showed that almost a third of imported  Asian  herbal remedies contained an active drug or heavy metal that was not mentioned on the label.

America's  Food and Drug Administration  [FDA]  has no immediate plans to tighten the regulation of herbal supplements.

But traditional firms could start making medical claims for their products and rake in the margins that other drugs enjoy, so long as they pay the roughly  $100 million  it costs [around late 90s value] to consider the clinical trials the FDA requires.

Some are already proving their worth. Studies to be published in the Journal of the  American Medical Association   on November 11th-  

Show the effectiveness of treating irritable bowel disease and  breach birth with traditional Chinese medicine.

With respectful dedication to the Students, Professors and Teachers of the world. See Ya all on !WOW!   -the World Students Society and........ Twitter-!E-WOW!  -the Ecosystem 2011:


''' !WOW! & !WOW! '''

Good Night and God Bless

SAM Daily Times - the Voice of the Voiceless

0 comments:

Post a Comment

Grace A Comment!